HomeFOLD • NASDAQ
add
Amicus Therapeutics, Inc.
Previous close
$11.00
Day range
$10.77 - $11.34
Year range
$9.02 - $14.57
Market cap
3.35B USD
Avg Volume
2.31M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 126.67M | 34.04% |
Operating expense | 100.44M | -2.27% |
Net income | -15.70M | 63.69% |
Net profit margin | -12.39 | 72.92% |
Earnings per share | 0.06 | 140.00% |
EBITDA | 17.15M | 212.95% |
Effective tax rate | 14,634.26% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 260.06M | -2.09% |
Total assets | 749.48M | 2.66% |
Total liabilities | 616.96M | -0.25% |
Total equity | 132.52M | — |
Shares outstanding | 296.59M | — |
Price to book | 24.44 | — |
Return on assets | 5.09% | — |
Return on capital | 6.50% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -15.70M | 63.69% |
Cash from operations | 22.69M | 240.65% |
Cash from investing | -21.98M | -143.95% |
Cash from financing | -857.00K | -103.62% |
Net change in cash | -437.00K | -100.89% |
Free cash flow | 35.49M | 336.70% |
About
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, PA. The company went public in 2007 under the NASDAQ trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates. Wikipedia
Founded
Feb 4, 2002
Website
Employees
517